Amylyx Pharmaceuticals AMLX
0.5501
0.04
7.11
%
已收盤：03/26 20:00 (臺灣)
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 3.78 | -0.55 | -40,654 | -38 | ||
| 2024Q3 | 3.24 | 104.07 | -1.07 | -75,661 | -73 | |
| 2024Q2 | 1.90 | -1.07 | -53,435 | -73 | ||
| 2024Q1 | 2.84 | 103.02 | 3.91 | -1.75 | -122,130 | -119 |
| 2023Q4 | 14.72 | 29.86 | 541.32 | 0.07 | 1,934 | 5 |
| 2023Q3 | 18.31 | 83.53 | 0.29 | 18,720 | 21 | |
| 2023Q2 | 21.57 | 84.15 | 0.32 | 20,201 | 22 | |
| 2023Q1 | 29.34 | -146.33 | 0.02 | -2,053 | 2 | |
| 2022Q4 | 36.95 | 105.86 | -0.62 | -44,593 | -43 | |
| 2022Q3 | 28.15 | 101.48 | -0.92 | -54,681 | -54 | |
| 2022Q2 | 19.26 | 100.67 | -0.92 | -54,253 | -54 | |
| 2022Q1 | 12.85 | 100.23 | -0.93 | -47,814 | -48 | |
| 2021Q4 | 99.90 | -4.15 | -28,315 | -28 | ||
| 2021Q3 | -0.42 | -22,918 | -23 | |||
| 2021Q2 | -0.48 | -18,587 | -22 | |||
| 2021Q1 | -0.32 | -12,868 | -15 | |||
| 2020Q4 | -8,592 | -9 | ||||
| 2019Q4 | 108.95 | -13,554 | -14 |
